<i>In-silico</i> Metabolome Target Analysis Towards <i>PanC</i>-based Antimycobacterial Agent Discovery

Abstract

Mycobacterium tuberculosis, the main cause of tuberculosis (TB), has still remained a global health crisis especially in developing countries. Tuberculosis treatment is a laborious and lengthy process with high risk of noncompliance, cytotoxicity adverse events and drug resistance in patient. Recently, there has been an alarming rise of drug resistant in TB. In this regard, it is an unmet need to develop novel antitubercular medicines that target new or more effective biochemical pathways to prevent drug resistant Mycobacterium.

Description

Keywords

Citation

URI

Endorsement

Review

Supplemented By

Referenced By